Chronic hepatitis D coinfection affects an estimated 12 million people globally, with higher prevalence in low-income and middle-income countries, especially the African and Western Pacific regions.
By Svea Herbst-Bayliss NEW YORK, March 17 (Reuters) - Activist investor Altai Capital Management called on OraSure Technologies to explore a sale, saying the medical device maker could fetch double ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results